Dianthus Therapeutics Banner

SEC Filing Details

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results

Document Details

Filing Date
Sep 21, 2023
Document Date
Sep 21, 2023
Form Description
Filing by person(s) reporting owned shares of common stock in a public company >5%
Filing Group
Other
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/